Viruses as an etiology of obesity

Mayo Clinic Proceedings

Volumn 82, Issue 10, 2007, Pages 1192-1198

  Atkinson, Richard L ^a  

^a Obetech Obesity Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; AVIADENOVIRUS; BORNA DISEASE VIRUS; CANINE DISTEMPER MORBILLIVIRUS; CELL DIFFERENTIATION; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 36; HUMAN ADENOVIRUS 37; HUMAN ADENOVIRUS 5; INTRAABDOMINAL FAT; LIPID METABOLISM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROADIPOCYTE; REVIEW; ROUS SARCOMA ONCOVIRUS; SCRAPIE AGENT; TRANSCRIPTION REGULATION; TWIN DISCORDANCE; VIRUS INFECTION;

EID: 34848896643     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.10.1192     Document Type: Review

References (71)

1. Bray GA, Champagne CM. Beyond energy balance: there is more to obesity than kilocalories. J Am Assoc. 2005;105(5, suppl 1):S17-S23.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288(14):1723-1727.
3. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291(23):2847-2850.
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288(14):1728-1732.
5. World Health Organization. Obesity: preventing and managing a global epidemic : report of a WHO consultation on obesity. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
6. James PT, Rigby N, Leach R, International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11(1):3-8.
7. Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond). 2006 Nov.30(11):1585-1594. Epub 2006 Jun 27.
8. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science. 1982;216(4541):82-85.
9. Carter JK, Ow CL, Smith RE. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun. 1983;39(1):410-422.
10. Narayan O, Herzog S, Frese K, Scheefers H, Rott R. Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science. 1983;220(4604):1401-1403.
11. Kim YS, Carp RI, Callahan SM, Wisniewski HM. Scrapie-induced obesity in mice. J Infect Dis. 1987;156(2):402-405.
12. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA. Avian adenovirus leading to pathognomic obesity in chickens. J Bombay Vet College. 1990; 2:131-132.
13. Summers BA, Appel MJ. Aspects of canine distemper virus and measles virus encephalomyelitis. Neuropathol Appl Neurobiol. 1994;20(6):525-534.
14. Vandevelde M, Zurbriggen A. The neurobiology of canine distemper virus infection. Vet Microbiol. 1995;44(2-4):271-280.
15. Bernard A, Zwingelstein G, Meister R, Fabian Wild T. Hyperinsulinemia induced by canine distemper virus infection of mice and its correlation with the appearance of obesity. Comp Biochem Physiol B. 1988;91(4):691-696.
16. Bernard A, Fevre-Montange M, Giraudon P, Hardin H, Fabian Wild T, Belin MF. Demonstration of viral proteins and RNA in hypothalamus of mice infected by canine distemper virus [in French]. C R Acad Sci III. 1991; 313(12):545-551.
17. Nagashima K, Zabriskie JB, Lyons MJ. Virus-induced obesity in mice: association with a hypothalamic lesion. J Neuropathol Exp Neurol. 1992; 51(1):101-109.
18. Bernard A, Fevre-Montange M, Bencsik A, et al. Brain structures selectively targeted by canine distemper virus in a mouse model infection. J Neuropath Exp Neurol. 1993;52(5):471-480.
19. Bencsik A, Akaoka H, Giraudon P, Belin MF, Bernard A. Inhibition of tyrosine hydroxylase expression within the substantia nigra of mice infected with canine distemper virus. J Neuropathol Exp Neurol. 1997;56(6):673-685.
20. Bernard A, Cohen R, Khuth ST, et al. Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus. J Virol. 1999;73(9):7317-7327.
21. Verlaeten O, Griffond B, Khuth ST, et al. Down regulation of melanin concentrating hormone in virally induced obesity. Mol Cell Endocrinol. 2001; 181(1-2)207-219.
22. Griffond B, Verlaeten O, Belin MF, Risold PY, Bernard A. Specific alteratior of the expression of selected hypothalamic neuropeptides during acute and late mouse brain infection using a morbillivirus: relevance to the late-onset obesity? Brain Res. 2004;1022(1-2):173-181.
23. Verlaeten O, Casery C, Cavagna S, et al. Identification of Urop11, a novel leptin-modulated gene that is upregulated in the hypothalamus of mice with virus-induced obesity. J Mol Endocrinol. 2007;38(1-2):3-17.
24. Brobeck JR. Mechanisms of the development of obesity in animals with hypothalamic lesions. Physiol Rev. 1946;26(4):541-559.
25. Carter JK, Garlich JD, Donaldson WE, Smith RE. Influence of diet on a retrovirus induced obesity and stunting syndrome. Avian Dis. 1983; 27(1):317-322.
26. Stitz L, Dietzschold B, Carbone KM. Immunopathogenesis of Borna disease. Curr Top Microbiol Immunol. 1995;190:75-92.
27. Rott R, Becht H. Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol. 1995;190:17-30.
28. Kao M, Hamir AN, Rupprecht CE, et al. Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA. Vet Rec. 1993;132(10):241-244.
29. Gosztonyi G, Ludwig H. Borna disease - neuropathology and pathogenesis. Curr Top Microbiol Immunol. 1995;190:39-73.
30. Hirano N, Kao M, Ludwig H. Persistent, tolerant or subacute infection in Borna disease virus-infected rats. J Gen Virol. 1983;64(pt 7):1521-1530.
31. Herden C, Herzog S, Richt JA, et al. Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain. Brain Pathol. 2000;10(1):39-48.
32. Ludwig H, Bode L, Gosztoyni G. Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol. 1988;35:107-151.
33. Richt JA, VandeWoude S, Zink MC, et al. Infection with Borna disease virus: molecular and immunobiological charecterization of the agent. Clin Infect Dis. 1992;14(6):1240-1250.
34. de la Torre JC. Molecular biology of Borna disease virus: prototype of a new group of animal viruses. J Virol. 1994;68(12):7669-7675.
35. Chen CH, Chiu YL, Wei FC, et al. High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan. Mol Psychiatry. 1999;4(1):33-38.
36. Chen CH, Chiu YL, Shaw CK, et al. Detection of Borna disease virus RNA from peripheral blood cells in schizophrenic patients and mental health workers. Mol Psychiatry. 1999;4(6):566-571.
37. Dietrich DE, Bode L, Spannahuth CW, et al. Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. Bipolar Disord. 2000;2(1):65-70.
38. Ferszt R, Kuhl KP, Bode L, et al. Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection. Pharmacopsychiatry. 1999;32(4):142-147.
39. Rott R, Herzog S, Fleischer B, et al. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science. 1985; 228(4700):755-756.
40. Bode L, Ludwig H. Borna disease virus infection, a human mental-health risk. Clin Microbiol Rev. 2003;16(3):534-545.
41. US Department of Agriculture. Scrapie. Available at: www.aphis.usda.gov/ lpa/pubs/fsheet_faq_notice/fs_ahscrapie.html. Accessed August 22, 2007.
42. Kim YS, Carp RI, Callahan SM, Wisniewski HM. Adrenal involvement in scrapie-induced obesity. Proc Soc Exp Biol Med. 1988;189(1):21-27.
43. Carp RL, Kim YS, Callahan SM. Pancreatic lesions and hypoglycemia- hyperinsulinemia in scrapie-injected hamsters. J Infect Dis. 1990;161(3):462-466.
44. Carp RI, Callahan SM, Yu Y, Sersen E. Analysis of host genetic control of scrapie-induced obesity. Arch Virol. 1993;133(1-2):1-9.
45. Ye X, Carp RI, Yu Y, Kozielski R, Kozlowski P. Hyperplasia and hypertrophy of B cells in the islets of Langerhans in hamsters infected with the 139H strain of scrapie. J Comp Pathol. 1994;110(2):169-183.
46. Ye X, Carp RI. The pathological changes in peripheral organs of scrapie-infected animals. Histol Histopathol. 1995;10(4):995-1021.
47. Ye X, Carp RI. Histopathological changes in the pituitary glands of female hamsters infected with the 139H strain of scrapie. J Comp Pathol. 1996; 114(3)291-304.
48. Ye X, Scallet AC, Carp RI. The 139H scrapie agent produces hypothalamic neurotoxicity and pancreatic islet histopathology: electron microscopic studies. Neurotoxicology. 1997;18(2):533-545.
49. Carp RL, Meeker H, Sersen E, Kozlowski P. Analysis of the incubation periods, induction of obesity and histopathological changes in senescence-prone and senescence-resistant mice infected with various scrapie strains. J Gen Virol. 1998;79(pt 11):2863-2869.
50. Ye X, Scallet A, Carp RI. Abnormal periodic acid-Schiff (PAS)-positive substance in the islets of Langerhans, pituitaries and adrenal glands of 139H scrapie-infected hamsters. Histol Histopathol. 1999;14(3):673-678.
51. Vorbrodt AW, Dobrogowska DH, Tarnawski M, Meeker HC, Carp RI. Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance. Acta Neuropathol (Berl). 2001;102(3):278-284.
52. Vorbrodt AW, Dobrogowska DH, Tarnawski M, Meeker HC, Carp RI. Immunogold study of altered expression of some interendothelial junctional molecules in the brain blood microvessels of diabetic scrapie-infected mice. J Mol Histol. 2006 Jan;37(1-2):27-35. Epub 2006 Aug 22.
53. Ajinkya SM. Final Technical Report, ICAR 1985. Bombay, India: Red and Blue Cross Publishing; 1985:13-43.
54. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA. Effect of adeno-virus infection on adiposity in chickens. Vet Microbiol. 1992;31(2-3):101-107.
55. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Association of adenovirus infection with human obesity. Obes Res. 1997; 5(5):464-469.
56. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol. 1999;37(12):3940-3945.
57. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord. 2000;24(8):989-996.
58. Kolesar JM, Miller JA, Dhurandhar NV, Atkinson RL. Direct quantification of AD-36 adenovirus DNA by capillary electrophoresis with laser-induced fluorescence. J Chromatogr B Biomed Sci Appl. 2000;744(1):1-8.
59. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL. Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord. 2001;25(7):990-996.
60. Dhurandhar NV, Whigham LD, Abbott DH, et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr. 2002;132(10):3155-3160.
61. Atkinson RL, Dhurandhar NV, Allison DB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond). 2005;29(3):281-286.
62. So PW, Herlihy AH, Bell JD. Adiposity induced by adenovirus 5 inoculation. Int J Obes (Lond). 2005;29(6):603-606.
63. Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R190-R194. Epub 2005 Sep 15.
64. Pasarica M, Shin AC, Yu M, et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring). 2006;14(11):1905-1913.
65. Greenway F. Virus-induced obesity [editorial]. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):R188-R189.
66. Wigand R, Gelderblom H, Wadell G. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol. 1980;64(3):225-233.
67. Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JWM. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis. 1988;158(4):804-813.
68. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res. 2004; 12(5):770-777.
69. Vangipuram SD, Yu M, Tian J, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond). 2007 Jan;31(1):87-96. Epub 2006 May 16.
70. Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond). 2007 Jan;31(1):78-86. Epub 2006 May 2.
71. Rogers PM, Fusinski KA, Rathod, MA, et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond). In press.